Gene · 701
Papers3,969
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 3,969
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Distinct cellular dynamics associated with response to CAR-T therapy for refractory B cell lymphoma. | Nat Med | 2022 | 36097221 | PubTator, text mining | PubMed |
| The identification of hub biomarkers and pathways in lung cancer and prognostic evaluation. | Transl Cancer Res | 2022 | 36093542 | PubTator, text mining | PubMed |
| Identification of a chromatin regulator signature and potential prognostic ability for adrenocortical carcinoma. | Front Genet | 2022 | 36092868 | PubTator, text mining | PubMed |
| Comprehensive analysis of GINS subunits prognostic value and ceRNA network in sarcoma. | Front Cell Dev Biol | 2022 | 36092720 | PubTator, text mining | PubMed |
| Transcriptome analysis of Homo sapiens and Mus musculus reveals mechanisms of CD8+ T cell exhaustion caused by different factors. | PLoS One | 2022 | 36084049 | PubTator, text mining | PubMed |
| Dysregulation of Pseudogenes/lncRNA-Hsa-miR-1-3p-PAICS Pathway Promotes the Development of NSCLC. | J Oncol | 2022 | 36081668 | PubTator, text mining | PubMed |
| DNA Damage Repair Classifier Defines Distinct Groups in Hepatocellular Carcinoma. | Cancers (Basel) | 2022 | 36077818 | PubTator, text mining | PubMed |
| ReDisX, a machine learning approach, rationalizes rheumatoid arthritis and coronary artery disease patients uniquely upon identifying subpopulation differentiation markers from their genomic data. | Front Med (Lausanne) | 2022 | 36072953 | PubTator, text mining | PubMed |
| Predicting AURKA as a novel therapeutic target for NPC: A comprehensive analysis based on bioinformatics and validation. | Front Genet | 2022 | 36072667 | PubTator, text mining | PubMed |
| A Narrative Review on Fanconi Anemia: Genetic and Diagnostic Considerations. | Glob Med Genet | 2022 | 36071913 | PubTator, text mining | PubMed |
| Cell-cycle and apoptosis related and proteomics-based signaling pathways of human hepatoma Huh-7 cells treated by three currently used multi-RTK inhibitors. | Front Pharmacol | 2022 | 36071844 | PubTator, text mining | PubMed |
| Identification and Validation in a Novel Classification of Helicase Patterns for the Prediction of Tumor Proliferation and Prognosis. | J Hepatocell Carcinoma | 2022 | 36061235 | PubTator, text mining | PubMed |
| PRR11 promotes cell proliferation by regulating PTTG1 through interacting with E2F1 transcription factor in pan-cancer. | Front Mol Biosci | 2022 | 36060253 | PubTator, text mining | PubMed |
| Micronuclei from misaligned chromosomes that satisfy the spindle assembly checkpoint in cancer cells. | Curr Biol | 2022 | 36057259 | PubTator, text mining | PubMed |
| The Four Causes: The Functional Architecture of Centromeres and Kinetochores. | Annu Rev Genet | 2022 | 36055650 | PubTator, text mining | PubMed |
| Identification of potential crucial genes and key pathways shared in Inflammatory Bowel Disease and cervical cancer by machine learning and integrated bioinformatics. | Comput Biol Med | 2022 | 36049413 | PubTator, text mining | PubMed |
| Identification and Validation of Three Hub Genes Involved in Cell Proliferation and Prognosis of Castration-Resistant Prostate Cancer. | Oxid Med Cell Longev | 2022 | 36035209 | PubTator, text mining | PubMed |
| Erratum to the genetic association between type 2 diabetic and hepatocellular carcinomas. | Ann Transl Med | 2022 | 36035008 | PubTator, text mining | PubMed |
| Novel insight into m6A regulator-mediated methylation modification patterns and immune characteristics in intracranial aneurysm. | Front Aging Neurosci | 2022 | 36034129 | PubTator, text mining | PubMed |
| Trip13 Depletion in Liver Cancer Induces a Lipogenic Response Contributing to Plin2-Dependent Mitotic Cell Death. | Adv Sci (Weinh) | 2022 | 36031387 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/701/papers?page=33